Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunological Memory01:23

Immunological Memory

17.9K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
17.9K
Vaccines01:21

Vaccines

42
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
42
Vaccinations01:51

Vaccinations

53.8K
Overview
53.8K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

10.0K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
10.0K
Allergic Reactions02:06

Allergic Reactions

33.6K
Overview
33.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A meta-analysis on the effectiveness of anthropomorphism in human-robot interaction.

Science robotics·2021
Same author

Fusion proteins consisting of Bet v 1 and Phl p 5 form IgE-reactive aggregates with reduced allergenic activity.

Scientific reports·2019
Same author

Infant milk formulas differ regarding their allergenic activity and induction of T-cell and cytokine responses.

Allergy·2016
Same author

Natural clinical tolerance to peanut in African patients is caused by poor allergenic activity of peanut IgE.

Allergy·2015
Same author

The high molecular weight glutenin subunit Bx7 allergen from wheat contains repetitive IgE epitopes.

Allergy·2014
Same author

Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014

Related Experiment Video

Updated: Mar 30, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

13.0K

Prophylactic mRNA Vaccination against Allergy Confers Long-Term Memory Responses and Persistent Protection in Mice.

E Hattinger1, S Scheiblhofer1, E Roesler1

  • 1Department of Molecular Biology, University of Salzburg, 5020 Salzburg, Austria.

Journal of Immunology Research
|November 12, 2015
PubMed
Summary

Messenger RNA (mRNA) vaccines against grass pollen allergy provide long-lasting protection. These vaccines induce robust immune memory for at least nine months, maintaining protection even with repeated allergen exposure.

More Related Videos

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

13.3K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.2K

Related Experiment Videos

Last Updated: Mar 30, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

13.0K
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

13.3K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.2K

Area of Science:

  • Immunology
  • Vaccinology

Background:

  • Messenger RNA (mRNA) vaccines offer a safer alternative to plasmid DNA vaccines for allergy prevention.
  • Concerns exist regarding the persistence of mRNA vaccine-induced memory responses and their efficacy during continuous allergen exposure.

Purpose of the Study:

  • To evaluate the duration of protective memory responses induced by mRNA vaccination against the grass pollen allergen Phl p 5.
  • To assess the maintenance of protective immune responses following repeated allergen challenges.

Main Methods:

  • Mice were vaccinated with mRNA encoding Phl p 5 and challenged with recombinant allergen at 3.5, 6, and 9 months post-vaccination.
  • A separate group of vaccinated mice underwent monthly aerosolized allergen challenges for 7 months.
  • Immune responses (antibodies, cytokines), lung inflammation, and airway hyperresponsiveness were analyzed.

Main Results:

  • mRNA vaccination elicited robust T-helper 1 (TH1) memory responses lasting at least 9 months.
  • Vaccination effectively suppressed T-helper 2 (TH2) cytokines, immunoglobulin E (IgE) levels, and lung eosinophilia.
  • Protection persisted after repeated allergen exposure, with no observed TH1-associated pathology and improved lung function compared to controls.

Conclusions:

  • mRNA vaccination against Phl p 5 induces durable, long-lived immune memory responses.
  • Allergen re-exposure effectively recalls protective memory without adverse effects.
  • mRNA vaccines meet the criteria for safe prophylactic use without requiring booster immunizations.